Dr. Madhav Danthala-Medical Oncologist in Somajiguda, Hyderabad

Dr. Madhav Danthala

MBBS, MD, DM (Medical Oncology)

Fellowship in Leukemia and Bone Marrow Transplantation

Medical Oncologist

  • Medical Oncologist
  • Bonemarrow Transplant
  • Haemato Oncologist
  • MBBS - PES Institute of Medical Sciences and Research - 2009 - Kuppam Verified Qualification
  • MD - Internal Medicine - Sri Devaraj Urs Medical College - 2013 - Kolar Verified Qualification
  • DM - Medical Oncology - Nizam’s Institute of Medical Sciences - 2017 - Hyderabad Verified Qualification
  • Operational Research Certificate Course - WHO, SORT IT, The Union - 2019 Verified Qualification
  • Fellowship in Leukemia and Bone Marrow Transplantation - Vancouver General Hospital, University of British Columbia - 2020 - Canada Verified Qualification
  • Resident Doctor - Department of Medical Oncology HCG Cancer Center - Bengaluru - Jun 2013 - Nov 2013
  • Consultant Hemato-Oncologist and BMT Physician Manipal Hospitals - Vijayawada - Sep 2017 - Jan 2022
  • Consultant Hemato-Oncologist and Bone Marrow Transplant Physician Yashoda Hospitals - Somajiguda - Feb 2022 - Aug Currently Working
  • 66157 Andhra Pradesh Medical Council 2010 Verified
Awards and Recognitions
  • University Topper (SDUAHER) Internal Medicine - 2013
  • Best Poster Presentation Award at ICON - 2016
  • ISMPO-Torrent Young Scholar Award - 2017
  • 1st Rank, DM Medical Oncology Entrance Examination, Nizam’s Institute of Medical Sciences
  • Performed the First Matched Sibling Donor and Haploidentical Stem Cell Transplant in Andhra Pradesh
  • Instrumental in Successfully Setting up the Allogeneic Stem Cell Transplant Program at Manipal Hospitals, Vijayawada and performed more than 50 Stem Cell Transplants, the Highest in the State
  • Medical Oncology Forum (MOF)
  • European Society of Medical Oncology (ESMO)
  • Collaborative Medical Oncology Group (CMOG)
  • American Society of Clinical Oncology (ASCO)
Paper Presentations
  • Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE Therapy in Patients with Neuroendocrine Tumours: 5 Years Experience from a Tertiary Cancer Care Centre in India. European Journal of Nuclear Medicine and Molecular Imaging. 2014 Jul;41(7):1319-26
  • Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62
  • Danthala M, Golamari KR, Seshachalam A, Mikkilineni A, Chappidi S, Mekala MB, Elangovan V, Chinnakali P. Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for HighRisk Acute Promyelocytic Leukemia. JCO Global Oncology. 2020 Nov;6:1749-56
  • Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: 8 Years Experience from a Tertiary Care Center in India. South Asian Journal of Cancer. 2016 Oct;5(04):176-8
  • Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study from South India. Clinical Lymphoma Myeloma and Leukemia. 2020 May 1;20(5):e205-11
  • Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of Global Oncology. 2019 Dec;5:1-3
  • Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long Term Survival and Late Side Effects of Paediatric Hodgkin Lymphoma Patients: A Study from a Tertiary Care Centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89
  • Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910
  • Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and Breast Cancer: Association of Serum Adiponectin, Leptin, and Adiponectin–Leptin Ratio as Risk Biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul;39(03):292-6
  • Danthala M, Lakshmaiah V. Correlative Study of Serum Cystatin C Levels with Severity of Acute Ischemic Stroke. J Clin Biomed Sci. 2013;3(4):188-92
  • Naveen L, Santoshi M, Madhav D, Sri Rama AG, Mahesh V. A Study of the Association of Insulin Resistance and Cardiometabolic Risk Factors in an Adult Population with Type 2 Diabetes Mellitus, Inter. J. Appl. Med. Sci. 2014;4:168-72
  • Proffered Paper: Additional Chromosomal Abnormalities in Chronic Myeloid Leukemia: Lest We Forget. Presented at ESMO (European Society of Medical Oncology) Asia 2016, Singapore
  • ?Generic Lmatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Presented at ASH 2016 (Annual American Society of Hematology Conference), San Diego. Shortlisted for Best of ASH
  • Microalbuminuric Anemia: A Study of the Relationship Between Hemoglobin Levels and Albuminuria In Diabetes. KAPICON - 2012
  • Obesity and Breast Cancer: Association of Serum Adiponectin, Leptin and Adiponectin-Leptin Ratio as Risk Biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology Conference at Delhi - 2016
  • Renal Reversibility in Multiple Myeloma: A Race Against the Clock! Presented at Myeloma: State of the Art, PGI Chandigarh - 2016
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: 8 years’ Experience from a Tertiary Care center in India. Presented at Annual Asian Clinical Oncology Society Conference , Delhi - 2016
  • Frontline Imatinib in Chronic Myeloid Leukemia: A Jewel in the Crown, Presented at Hematocon , Jaipur - 2016
  • Pediatric Chronic Myeloid Leukemia: Wise to Generalize? Presented at ISMPOCON , Delhi - 2016
  • Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/ M1 with prior Myelodysplastic Syndrome Transformed from Fanconi Anemia – A Case Report. HEMATOCON - 2015
  • Phenytoin Induced Cerebellar Ataxia and Orofacial Dyskinesia in a Rare Case of Disseminated Cysticercosis. APICON - 2013

Report an error

Practice Locations


Rajbhavan Road

Matha Nagar

Opp Adp Office

Somajiguda , Hyderabad

Fee : ₹ 850


Get direction


OP Timings

Mon - Sat 09:00 am - 05:00 pm

No feedback

No feedback available for this doctor.
Be the first to write a review.

Write a review
Write a review

Write a review for Dr. Madhav Danthala

Which clinic or hospital you visited

I Recommend this Doctor for

Write your experience aboutDr. Madhav Danthala

Articles from Dr. Madhav Danthala

No Articles

No articles written by this doctor.

Read more articles

Question & Answers from Dr. Madhav Danthala

No Questions

No Question & Answers by this doctor.

skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

  • Home
  • Search
  • Doctors
  • Hospitals